je.st
news
Perrigo shareholders reject $26B bid from drug rival Mylan
2015-11-13 16:12:40| Biotech - Topix.net
Mylan said that its cash-and-stock offer failed to garner enough interest from Perrigo shareholders by a Friday morning deadline to complete the deal.
Tags: drug
bid
shareholders
reject
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||